click below
click below
Normal Size Small Size show me how
GI Disorders
Cell Types
| Cell Type | Normal function | Stimulate by | Inhibited by | Effect – H. pylori PUD (urease | Effect – NSAID PUD |
|---|---|---|---|---|---|
| Parietal cell | Secretes H+ (gastric acid) | ACh (M3R), Histamine (H2R), Gastrin (CCKR) | Prostaglandins, Somatostatin | ↑ acid via ↑ gastrin → ↑ ECL histamine | ↑ acid (loss of PGE-mediated inhibition) |
| G cell | Secretes gastrin | ACh, GRP, peptides/aa | Somatostatin | ↑ gastrin | Generally unchanged |
| D cell | Secretes somatostatin (SST) | High [H+] (low pH) | Low [H+] (high pH); Ach | ↓ SST (disinhibits gastrin and histamine) | No primary direct change |
| Enterochromaffin-like (ECL) cell | Secretes histamine | ACh (M3) and Gastrin (CCK) | Somatostatin | ↑ histamine (2/2 hypergastrinemia) | No primary direct change |
| Mucous cell | Secretes mucus and HCO3- (barrier protection) | ACh, Prostaglandins, Somatostatin | Low PGE, SST | Barrier compromised by inflammation (functional reduction) | ↓ mucus/HCO3- due to ↓ prostaglandins |
| H+/K+/-ATPase (Proton pump) | Final pathway for acid secretion; exchanges H+ for K+ in parietal cells | Activated downstream of ACh (M3), Histamine (H2), Gastrin (CCK-B) | Prostaglandins, Somatostatin; PPIs directly inhibit pump | ↑ activity due to ↑ gastrin → ↑ ECL histamine | ↑ activity due to loss of PGE inhibition |
| H2 receptor (Parietal cell) | ↑ cAMP → ↑ H+ secretion | Histamine from ECL cells | Somatostatin; H2 blockers | ↑ activation due to ↑ ECL histamine | No primary change |
| M3 receptor (Parietal cell receptor) | Increase intracellular Ca2+ to drive acid secretion | Acetylcholine (vagal input) | Somatostatin; antimuscarinics | Indirect ↑ effect via ↓ SST | No primary change |
| CCK-B receptor (Parietal & ECL receptor) | Gastrin → CCK-B → ↑ H+ secretion & ↑ histamine release | Gastrin from G cells | Somatostatin | ↑ activation due to ↑ gastrin | No primary change |
| Acetylcholine | Stimulate muscarinic M3 signaling to increase intracellular Ca2+ | Cephalic-phase: sight/smell/taste/ingestion | Somatostatin (reduces ACh effects on D-cells); antimuscarinics (not primary in this deck) | Relative ↑ effect via ↓ SST (D-cell) disinhibition | No primary change |
| CCK-B (gastrin receptor) | Stimulate parietal H+ secretion and ECL histamine release | Gastrin from G-cells (triggered by peptides/aa; GRP) | Somatostatin | ↑ activation due to hypergastrinemia | No primary change |
| Peptides/amino acids; GRP (trigger for gastrin) | Stimulate G-cells to release gastrin | Protein in lumen; vagal GRP | Somatostatin | Amplifies ↑ gastrin state (disinhibited G-cells) | No primary change |
| cAMP (parietal cell) | Second messenger downstream of H2 to activate H+/K+-ATPase | Histamine → H2 (Gs) | Prostaglandins; H2 antagonists (pharmacologic) | ↑ drive via ↑ histamine from ECL | Relative ↑ due to loss of PGE brake |
| Prostaglandins (PGE) | Inhibit parietal acid and stimulate mucus/HCO3- production | Arachidonic acid via COX | NSAIDs (COX inhibition) | No primary change (physiology intact) | ↓ PGE → ↓ mucus/HCO3, blood flow → gastric acid secretion |